53 reports

  • The Future: What Next for Pain Relief?
  • Portable and palatable pain relief
  • Analgesic
  • OTC
  • Pain Relief
  • World
  • Demand
  • Market challenges

In 2016, the OTC medicines market reached $##. ## billion in the US alone, where the pain relief segment accounted for ##. ##% of overall market share.

  • Pain Relief
  • World
  • Market Size
  • Sigma-Aldrich
  • Thermo Fisher Scientific, Inc.
  • BAYER HEALTHCARE

These are designed particularly for pain relief.

  • Pain Relief
  • World
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Pain Therapeutics Market, Global, Approved Indications for Voltaren, 2017
  • 4.5 Conclusion

This class of drugs provides potent pain relief.

  • Pain Relief
  • World
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • 7.1.5 RIZAPORT (RIZATRIPTAN BENZOATE)
  • 6.5 JAPAN

And there is no prophylactic drug that negates the need for pain relief. "

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

Moreover the favorable reimbursement policies in the prescribes drugs has driven the market acceptance of chronic USD ##. ## billion in the year 2015. pain relief drugs in the market. ##. ## ##. ## ##. ## CAGR:##. ##% Figure ##: Japan Pain Management Drugs Market Size, By Value, 2011-2015 (USD Billio

  • Pain Relief
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.

In Consumer Health, for the first time a separate division within Bayer AG, the company is focusing R& D activities on dermatologicals, dietary supplements, pain relief, gastrointestinal complaints, allergy relief and cold symptoms, as well as foot and sun care products.

  • Pain Relief
  • Bayer AG
  • Herbalife Ltd.
  • Pfizer Inc.
  • Sanofi S.A.

PAIN RELIEF REMEDIES GROWTH IN ALTERNATIVE THERAPIES CHAPTER ##: PAIN AILMENTS AND SUFFERERS RESPONDING TO PAIN AND SICKNESS: A NUANCED APPROACH Table ##-##: How Consumers Respond to Pain and Sickness: Adults Reporting Moderate-to- Severe Suffering, by Illness/ Condition, 2016 GATHERI

  • Chronic Pain
  • Healthcare
  • Pain Relief
  • United States
  • Demand
  • DATA PARAMETERS AND REPORT DEFINITIONS (1)
  • REPORT DEFINITIONS (2)

PASSPORT ## REPORT DEFINITIONS REPORT DEFINITIONS (##) Paediatric analgesics: All analgesics specifically designed, marketed and labelled for pain relief in children.

  • Pain Relief
  • Demand
  • Bayer AG
  • GlaxoSmithKline plc
  • Pfizer Inc.

##. ## Solubility: A Hindrance to Drug Development ##. ## Monoclonal Antibodies (MAbs) – Potential Novel Pain Drugs Facing Challenges ##. ## New Opioids Providing Opportunities for Growth ##. ## The Potential Use of Cannabinoids In Pain Relief ##.

  • OTC
  • Pain Relief
  • World
  • Demand
  • Forecast

and Others ## Table ##: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others ## Table ##: Market Shares of Leading Oral

  • Opioid
  • Pain Relief
  • United States
  • Demand
  • Market Shares

pain relief drug October 2015: Alder BioPharmaceuticals commenced its pivotal clinical trials for ALD## (a transformative monoclonal antibody targeting CGRP) being developed for the prevention of frequent episodic migraine October 2015: CoLucid Pharmaceuticals initiated Phase III long-term

  • Pain Relief
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.

Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others.............. ## Table ##: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Ot

  • Opioid
  • Pain Relief
  • United States
  • Demand
  • Market Shares
  • Availability of Morphine (in mg) Compared vs % Population Aged 65+ 2014
  • Data parameters and report definitions (1)

Different brands accomplish this in different ways: Aleve (Bayer AG), for example, opts for extendedrelease action in its tablets, delivering ## hours of pain relief in one dose of ##mg of naproxen sodium, building on its consistent message of " all day pain relief. "

  • Analgesic
  • Pain Relief
  • Therapy
  • World
  • Demand
  • Major market segmentation (2016-17)
  • Products & Markets

Salicylates derivatives in the pain-relief market.

  • Pain Relief
  • Pharmaceutical
  • Australia
  • Forecast
  • Trade
  • Chapter IV

INJECTABLE LOCAL ANESTHETICS PROVIDE PAIN RELIEF FOR SOME PART OF THE BODY DURING SURGERY, DENTAL PROCEDURES, OR OTHER MEDICAL PROCEDURES.

  • Pain Relief
  • China
  • Demand
  • Trade
  • Yichang Humanwell Pharmaceutical Co.
  • REGIONAL OVERVIEW

PASSPORT ## STEADY REGIONAL GROWTH DRIVEN BY CHINA REGIONAL OVERVIEW The accelerated ageing of the population in China and Japan contributed to the region' s steady growth over the past ## years, as elderly consumers consider pain relief the major and first problem to solve and increase

  • Pain Relief
  • Asia
  • China
  • Kowa Co., Ltd.
  • Sanofi S.A.
  • interviews
  • Passport 2

Since October 2014, Canadian golf icon and eight-time PGA Tour winner Mike Weir has been representing the Aleve brand in Canada as a pain relief product for arthritis.

  • Allergy Drug
  • Pain Relief
  • Canada
  • Demand
  • Bayer AG

IN JULY 2014, GSK RECALLED PANADOL ADVANCE ## CT PAIN RELIEF PRODUCTS FROM PUERTO RICO CONSUMERS, AS IT LACKED A CHILD RESISTANT FEATURE AND IS NOT LABELED AS A PRODUCT " FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN".

  • Pain Relief
  • Canada
  • North America
  • Mylan Inc.
  • Pfizer Inc.
  • REGIONAL OVERVIEW

PASSPORT ## REGIONAL OVERVIEW REGIONAL OVERVIEW BY CATEGORY The trend towards topical analgesics continues across the region overall, as consumers grow more wary of ingesting chemicals and gravitate more towards topicals, which are perceived as providing the same degree of pain relief but wi

  • Analgesic
  • Pain Relief
  • Europe
  • Demand
  • Bayer AG
  • BAYER HUNGÁRIA KFT

Due to continuous innovation activity of Bayer AG, the company' s share is set to rise and it is expected to gain further share after the launch of the new Aspirin product offering twice as fast pain relief due to the micro-active technology and rapid dispersing of the medicine.

  • OTC
  • Pain Relief
  • Hungary
  • Demand
  • Bayer AG
  • GSK- Revenues from Imigran/Imitrex Migraine Drugs Brands
  • 9.3 GLAXOSMITHKLINE (GSK)

However, rizatriptan may provide better pain relief than many of the other triptans.

  • Pain Relief
  • Endo International plc
  • GlaxoSmithKline plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • Analgesics and Other Pain Relievers
  • COMPANY: PRESTIGE BRANDS HOLDINGS, INC. ADDRESS: 660 WHITE PLAINS RD.

It may be combined with other drugs to provide even greater pain relief.

  • Pain Relief
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SENSUS RLS - USE OF WEARABLE PAIN RELIEF TECHNOLOGY IN RESTLESS LEG SYNDROME
  • FEB 21, 2017: NEUROMETRIX ANNOUNCES AVAILABILITY OF QUELL WEARABLE PAIN RELIEF TECHNOLOGY AT BEST BUY
  • Pain Relief
  • United States
  • Company Financials
  • Product Initiative
  • NeuroMetrix, Inc.
  • The promotion of Bufferin Premium reaffirms the product benefits

Hybrid Aleve PM available in the US combines sleep aid and pain relief.

  • Analgesic
  • Pain Relief
  • Therapy
  • Japan
  • Demand

Worth to note is the rapidly installed and long lasting pain relief achieved by the MCS-Injection therapy.

  • Neurology
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION
  • PAIN RELIEF DEVICE - PRODUCT STATUS
  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company
  • 4.3 Challenges

Slow Onset: While triptans have improved the treatment of migraine, their onset of pain relief is relatively slow.

  • OTC
  • Pain Relief
  • United States
  • World
  • Amgen Inc.
  • MTR-106 - DRUG PROFILE
  • KETOPROFEN - DRUG PROFILE

A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Antimigraine
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • Nov 30, 2015: CapGenesis Files Five Orphan Drug Designation Requests with the FDA and EMA for CGS-200 as a Topical Analgesic
  • Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Drug Profiles

The authors conclude that the capsaicin ##% patch provided non-inferior pain relief compared with pregabalin, in addition to a shorter median time to pain relief, fewer systemic side effects and greater treatment satisfaction.

  • Hospital
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.